Apple Signs Vox for News Subscription Service
(Bloomberg) -- Apple Inc. signed Vox to be part of an upcoming subscription service for newspaper and magazine readers, according to a person familiar with the matter, adding the popular explainer website to a lineup that's due to be announced next week.
The site is owned by Vox Media Inc., which also publishes the Verge, SBNation and Eater, though its other properties won't be part of the service initially, said the person, who asked not to be identified because the accord hasn't been announced.
Apple is in the process of lining up contributors to the new offering, which has been dubbed Apple News Magazines inside the company. Apple acquired a company called Texture last year to help it build the service. It had arrangements with over 200 magazines.
Apple and Vox Media declined to comment.
The service is designed to let consumers subscribe to a bundle of newspapers and magazines for a flat monthly fee. Apple's comparable service for music, Apple Music, costs users about $10 month. The Cupertino, California-based company plans to announce the news service, a video-streaming offering and a credit card in partnership with Goldman Sachs Group Inc. next week, Bloomberg News has reported.
Vox was co-founded in 2014 by Ezra Klein, Melissa Bell and Matthew Yglesias. Vox Media doesn't currently offer subscriptions to its content, but Chief Executive Officer Jim Bankoff said this month at the South by Southwest conference he would add a subscription model later this year with membership tiers.
To contact the reporter on this story: Mark Gurman in San Francisco at mgurman1@bloomberg.net
To contact the editors responsible for this story: Nick Turner at nturner7@bloomberg.net, Rob Golum
©2019 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.